The kinetics of cardiopulmonary bypass: A dual-platform proteomics study of plasma biomarkers in pediatric patients undergoing cardiopulmonary bypass

Artificial Organs

Volumn 36, Issue 1, 2012, Pages

  Umstead, Todd M ^a   Lu, Chia Jung K ^a   Freeman, Willard M ^b   Myers, John L ^a,b   Clark, J Brian ^a,b   Thomas, Neal J ^a,b   Icitovic, Nikolina ^b   Chinchilli, Vernon M ^b   Ündar, Akif ^a,b   Phelps, David S ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Cardiopulomonary bypass; Dual platform proteomics; Pediatric; Prediction model

Indexed keywords

BIOMARKERS; ELECTROPHORESIS; FORECASTING; MASS SPECTROMETRY; MOLECULAR BIOLOGY; PATIENT TREATMENT; PEDIATRICS;

2D DIGE; CARDIOPULMONARY BYPASS; CARDIOPULOMONARY BYPASS; DUAL-PLATFORM PROTEOMIC; MULTI-ANALYTES; PEDIATRIC PATIENTS; PREDICTION MODELLING; PROTEOMIC APPROACHES; PROTEOMIC STUDIES; TIME POINTS;

PROTEINS;

ALPHA 1 ANTICHYMOTRYPSIN; ALPHA 2 ANTIPLASMIN; ALPHA1 GLYCOPROTEIN; ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; ANGIOTENSINOGEN; ANTITHROMBIN III; APOLIPOPROTEIN A1; APOLIPOPROTEIN A4; APOLIPOPROTEIN E; BETA2 GLYCOPROTEIN 1; BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR 13B; CERULOPLASMIN; CLUSTERIN; COMPLEMENT COMPONENT C1; COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT C6; COMPLEMENT COMPONENT C8; COMPLEMENT FACTOR H; COMPLEMENT FACTOR I; CYTOKERATIN 10; CYTOKERATIN 9; FETUIN A; FIBRINOGEN; GELSOLIN; GLIA MATURATION FACTOR; HEMOPEXIN; INTER ALPHA TRYPSIN INHIBITOR; PIGMENT EPITHELIUM DERIVED FACTOR; THROMBIN;

AMINO ACID SEQUENCE; ARTICLE; CARDIOPULMONARY BYPASS; CHILD; CLINICAL ARTICLE; FEMALE; FUNCTIONAL PROTEOMICS; HEART SURGERY; HUMAN; HUMAN TISSUE; INFANT; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; OUTCOME ASSESSMENT; PEDIATRIC SURGERY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; STATISTICAL MODEL; STRUCTURAL PROTEOMICS; SURGICAL PATIENT; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

EID: 84856022092     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2011.01412.x     Document Type: Article

References (16)

1. Paśnik J, Moll J, Cywińska-Bernas A, Moll J, Sysa A, Zeman K. Proteolytic and cytokine balance abnormalities in children with congenital heart disease undergoing cardiac surgery with cardiopulmonary bypass. Kardio Pol 2006;65:1208-14.
2. Day JR, Taylor KM. The systemic inflammatory response syndrome and cardiopulmonary bypass. Int J Surg 2005;3:129-40.
3. Seghaye MC. The clinical implications of the systemic inflammatory reaction related to cardiac operations in children. Cardiol Young 2003;13:228-39.
4. Kumar RA, Cann C, Hall JE, Sudheer PS, Wilkes AR. Predictive value of IL-18 and SC5b-9 for neurocognitive dysfunction after cardiopulmonary bypass. Br J Anaesth 2007;98:317-22.
5. Holmes JH 4th, Connolly NC, Paull DL, etal. Magnitude of the inflammatory response to cardiopulmonary bypass and its relation to adverse clinical outcomes. Inflamm Res 2002;51:579-86.
6. Rothenburger M, Soeparwata R, Deng MC, etal. Prediction of clinical outcome after cardiac surgery: the role of cytokines, endotoxin, and anti-endotoxin core antibodies. Shock 2001;16(Suppl. 1):44-50.
7. Alcaraz AJ, Manzano L, Sancho L, etal. Different proinflammatory cytokine serum pattern in neonate patients undergoing open heart surgery. Relevance of IL-8. J Clin Immunol 2005;25:238-45.
8. Kozik DJ, Tweddell JS. Characterizing the inflammatory response to cardiopulmonary bypass in children. Ann Thorac Surg 2006;81:S2347-54.
9. Dent CL, Ma Q, Dastrala S, etal. Plasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study. Crit Care 2007;11:R127.
10. Lull ME, Carkaci-Salli N, Freeman WM, etal. Plasma biomarkers in pediatric patients undergoing cardiopulmonary bypass. Pediatr Res 2008;63:638-44.
11. Umstead TM, Freeman WM, Chinchilli VM, Phelps DS. Age-related changes in the expression and oxidation of bronchoalveolar lavage proteins in the rat. Am J Physiol Lung Cell Mol Physiol 2009;296:L14-L29.
12. Gibson F, Anderson L, Babnigg G, etal. Guidelines for reporting the use of gel electrophoresis in proteomics. Nat Biotechnol 2008;26:863-4.
13. Thomas PD, Campbell MJ, Kejariwal A, etal. PANTHER: a library of protein families and subfamilies indexed by function. Genome Res 2003;13:2129-41.
14. Mi H, Lazareva-Ulitsky B, Loo R, etal. The PANTHER database of protein families, subfamilies, functions and pathways. Nucleic Acids Res 2005;33:284-8.
15. Valet G. Predictive medicine by cytomics: potential and challenges. J Biol Regul Homeost Agents 2002;16:164-7.
16. Jenkins KJ. Risk adjustment for congenital heart surgery: the RACHS-1 method. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2004;7:180-4 (Reference for Table 1).